About this trial
In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used. When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems. While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms. Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR). High-quality prospective evidence on rTAR is currently lacking.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Pregnant or suspected pregnancy
Not-curatively treated malignancy, with life expectancy less than 24 months
Patients unable to give informed consent or complete study specific questionnaires
Emergency surgery
Trial design
Parallel
Treatments tested in this trial
incisional hernia repair
Procedure/SurgeryIncisional hernia repair for the treatment of wide ventral incisional hernias.
Treatment groups
Trial outcomes
Primary outcomes
Length of postoperative hospital stay
Length of postoperative hospital stay
Secondary outcomes
Skin-to-skin operative time
Skin-to-skin operative time from first incision until last skin suture
Conversion rate
Conversion rate from the robotic-assisted approach to the open approach
Surgical site related complications
Surgical site infection - surgical site occurrence - surgical site occurrence requiring procedural interventions
Readmission rate
Readmission rate
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: